The pulmonary alveolar epithelium, which covers >99% of the internal surface area of the lung, is comprised of two types of cells, type I (Tl) and type 11 (Til) cells, both of which are believed to be essential for mammalian life. The current accepted paradigm for cell lineage in the lung is that TH cells are the progenitor cells in the lung, transdifferentiating into Tl cells both in development and in response to lung injury. From both evidence in the literature and recent Preliminary Data, this model does not completely explain more recent experimental observations. Our underlying hypothesis is that alveolar epithelial differentiation, both in lung development and following lung injury, involves more complex pathways than a simple linear progression from the Til to the Tl cell phenotype. The experiments we propose in Specific Aims #1 and #2 will test this hypothesis by fate mapping of irreversibly-marked cells both in development (Aim #1) and following injury (Aim #2). From the studies in Aim #1, we will determine cell fates using transgenic constructs to permanently express EGFP in various cell lineages at different fimes in development.
In Specific Aim #3, we will identify gene expression profiles of permanentiy marked cells in different lineages at various times in development, thus characterizing how expression profiles change with progressive differentiation. Using established and novel statistical methods, we will identify candidate regulatory molecules and gene networks. We will test candidate genes with Tl, TH and fetal alveolar epithelial cells in vitro to evaluate promising regulatory genes and networks. The results of these experiments should provide novel insights into alveolar epithelial cell lineage pathways both in development and in lung repair and are likely to identify candidate gene networks that play a role in regulating alveolar epithelial development. The results may provide the basis for developing therapeutic strategies that are testable in vivo. Identification of key pathways and relevant gene networks could lead to the development of novel diagnostic and therapeutic agents.
|Barrette, Anne Marie; Roberts, Jessica K; Chapin, Cheryl et al. (2016) Antiinflammatory Effects of Budesonide in Human Fetal Lung. Am J Respir Cell Mol Biol 55:623-632|
|Danhaive, Olivier; Chapin, Cheryl; Horneman, Hart et al. (2015) Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B. Pediatr Res 77:340-6|
|Vanderbilt, Jeff N; Gonzalez, Robert F; Allen, Lennell et al. (2015) High-efficiency type II cell-enhanced green fluorescent protein expression facilitates cellular identification, tracking, and isolation. Am J Respir Cell Mol Biol 53:14-21|
|Gonzales, Linda W; Gonzalez, Robert; Barrette, Anne Marie et al. (2015) Expression of Carcinoembryonic Cell Adhesion Molecule 6 and Alveolar Epithelial Cell Markers in Lungs of Human Infants with Chronic Lung Disease. J Histochem Cytochem 63:908-21|
|Raymond, Wilfred W; Xu, Xiang; Nimishakavi, Shilpa et al. (2015) Regulation of hepatocyte growth factor in mice with pneumonia by peptidases and trans-alveolar flux. PLoS One 10:e0125797|
|LaFemina, Michael J; Sutherland, Katherine M; Bentley, Trevor et al. (2014) Claudin-18 deficiency results in alveolar barrier dysfunction and impaired alveologenesis in mice. Am J Respir Cell Mol Biol 51:550-8|
|Gonzalez, Robert F; Dobbs, Leland G (2013) Isolation and culture of alveolar epithelial Type I and Type II cells from rat lungs. Methods Mol Biol 945:145-59|
|Chapin, Cheryl; Bailey, Nicole A; Gonzales, Linda W et al. (2012) Distribution and surfactant association of carcinoembryonic cell adhesion molecule 6 in human lung. Am J Physiol Lung Cell Mol Physiol 302:L216-25|
|Heine, Vivi M; Griveau, Amelie; Chapin, Cheryl et al. (2011) A small-molecule smoothened agonist prevents glucocorticoid-induced neonatal cerebellar injury. Sci Transl Med 3:105ra104|
|Gonzalez, Robert F; Allen, Lennell; Gonzales, Linda et al. (2010) HTII-280, a biomarker specific to the apical plasma membrane of human lung alveolar type II cells. J Histochem Cytochem 58:891-901|
Showing the most recent 10 out of 176 publications